ARG56151

anti-DHCR7 antibody

anti-DHCR7 antibody for ICC/IF,Western blot and Human,Mouse

Overview

Product Description Rabbit Polyclonal antibody recognizes DHCR7
Tested Reactivity Hu, Ms
Tested Application ICC/IF, WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name DHCR7
Antigen Species Human
Immunogen KLH-conjugated synthetic peptide corresponding to aa. 437-463 (C-terminus) of Human DHCR7.
Conjugation Un-conjugated
Alternate Names 7-DHC reductase; SLOS; EC 1.3.1.21; 7-dehydrocholesterol reductase; Putative sterol reductase SR-2; Sterol Delta

Application Instructions

Application Suggestion
Tested Application Dilution
ICC/IF1:10 - 1:50
WB1:1000
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.
Positive Control HepG2

Properties

Form Liquid
Purification Purification with Protein A and immunogen peptide
Buffer PBS and 0.09% (W/V) Sodium azide.
Preservative 0.09% (W/V) Sodium azide.
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 13360 Mouse DHCR7

GeneID: 1717 Human DHCR7

Swiss-port # O88455 Mouse 7-dehydrocholesterol reductase

Swiss-port # Q9UBM7 Human 7-dehydrocholesterol reductase

Gene Symbol DHCR7
Gene Full Name 7-dehydrocholesterol reductase
Background This gene encodes an enzyme that removes the C(7-8) double bond in the B ring of sterols and catalyzes the conversion of 7-dehydrocholesterol to cholesterol. This gene is ubiquitously expressed and its transmembrane protein localizes to the endoplasmic reticulum membrane and nuclear outer membrane. Mutations in this gene cause Smith-Lemli-Opitz syndrome (SLOS); a syndrome that is metabolically characterized by reduced serum cholesterol levels and elevated serum 7-dehydrocholesterol levels and phenotypically characterized by mental retardation, facial dysmorphism, syndactyly of second and third toes, and holoprosencephaly in severe cases to minimal physical abnormalities and near-normal intelligence in mild cases. Alternative splicing results in multiple transcript variants that encode the same protein.[provided by RefSeq, Aug 2009]
Function Production of cholesterol by reduction of C7-C8 double bond of 7-dehydrocholesterol (7-DHC). [UniProt]
Calculated MW 54 kDa